LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

Home・Elenco Azioni・Treace Medical Concepts Inc

Treace Medical Concepts Inc

Chiusa

1.85 1.65

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

1.81

Massimo

1.92

Metriche Chiave
By Trading Economics
Entrata	1.1M -16M
Vendite	2.8M 50M
Margine di Profitto	-32.437
Dipendenti	477
EBITDA	1.3M -12M

Raccomandazioni
By TipRanks
Raccomandazioni	Neutrale
Previsioni per 12 mesi	+132.8% upside

Dividendi
By Dow Jones
Utili prossimi	27 feb 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-298M 119M
Apertura precedente	0.2
Chiusura precedente	1.85

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

7.16 / 7.65 Supporto e resistenza

Treace Medical Concepts Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

18 feb 2026, 22:31 UTC

Utili

Brambles Raises Dividend, Cash-Flow Guidance as 1st Half Profit Jumps -- Update

18 feb 2026, 22:18 UTC

Utili

Wal-Mart de Mexico 4Q Profit Falls, Hit by Higher Taxes

18 feb 2026, 22:11 UTC

Utili

Wesfarmers Boosts Dividend After 1st Half Profit Rises -- Update

18 feb 2026, 21:52 UTC

Utili

Telstra Boosts Dividend as First-Half Earnings Rise 5.5% -- Update

18 feb 2026, 23:56 UTC

Discorsi di Mercato

Santos's Review of Domestic Assets Could Lead to Simpler Portfolio -- Market Talk

18 feb 2026, 23:46 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

18 feb 2026, 23:46 UTC

Discorsi di Mercato

Nikkei May Rise After U.S. Tech Stock Gains -- Market Talk

18 feb 2026, 23:34 UTC

Discorsi di Mercato

Utili

Brambles' Cost Control Stands Out to Bull -- Market Talk

18 feb 2026, 23:33 UTC

Discorsi di Mercato

Gold Edges Higher Amid Growing Risks of U.S.-Iran Conflict -- Market Talk

18 feb 2026, 23:32 UTC

Discorsi di Mercato

Australia Jobs Data Will Likely Support May Hike Assumptions -- Market Talk

18 feb 2026, 22:45 UTC

Utili

DoorDash Stock Rebounds. Earnings and Revenue Both Fall Short. -- Barrons.com

18 feb 2026, 22:44 UTC

Discorsi di Mercato

Investors Eyeing Nvidia's Revenue Visibility Ahead of 4Q Print -- Market Talk

18 feb 2026, 22:37 UTC

Utili

Nutrien 4Q EPS $1.18 >NTR.T

18 feb 2026, 22:37 UTC

Utili

Nutrien 4Q Sales $5.34B >NTR.T

18 feb 2026, 22:35 UTC

Utili

Pan American Silver 4Q EPS $1.07 >PAAS

18 feb 2026, 22:35 UTC

Utili

Pan American Silver 4Q Rev $1.18B >PAAS

18 feb 2026, 22:30 UTC

Utili

Kinross Gold Raises Quarterly Dividend to 4c Vs. 3.5c >K.T

18 feb 2026, 22:29 UTC

Utili

Kinross Gold 4Q EPS 75c >K.T

18 feb 2026, 22:22 UTC

Utili

Coeur Mining: Full-Yr 2026 Production Is Expected to Be 55,000 - 65,000 Ounces of Gold and 5.5M - 6.3M Ounces of Silver >CDE

18 feb 2026, 22:22 UTC

Discorsi di Mercato

Nvidia 4Q Earnings Coming Amid China Export Battle -- Market Talk

18 feb 2026, 22:16 UTC

Utili

Brambles Raises Dividend, Cash-Flow Guidance as 1H Profit Jumps -- Update

18 feb 2026, 22:05 UTC

Utili

Pan American Silver Reports Record Fourth Quarter And Full Year 2025 Financial Results; Record Cash Flow From Operations Of $554 Million In The Fourth Quarter; Dividend Increased By 29% >PAAS

18 feb 2026, 22:03 UTC

Utili

Kaiser Aluminum Expects to Improve Conversion Rev by 5% to 10% and Adj EBITDA by 5% to 15% for FY26 >KALU

18 feb 2026, 22:02 UTC

Utili

Kaiser Aluminum 4Q Adj EPS $1.53 >KALU

18 feb 2026, 22:02 UTC

Utili

Kaiser Aluminum 4Q Sales $929M >KALU

18 feb 2026, 22:02 UTC

Utili

Kaiser Aluminum 4Q EPS $1.68 >KALU

18 feb 2026, 22:00 UTC

Utili

Kinross Gold 4Q Adj EPS 67c >KGC

18 feb 2026, 22:00 UTC

Utili

Kinross Gold 4Q Sales $2.02B >KGC

18 feb 2026, 21:56 UTC

Utili

Wesfarmers Boosts Dividend After 1H Profit Rises -- Update

18 feb 2026, 21:50 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

Confronto tra pari

Modifica del prezzo

Treace Medical Concepts Inc Previsione

Obiettivo di Prezzo

By TipRanks

132.8% in crescita

Previsioni per 12 mesi

Media 4.33 USD 132.8%

Alto 7.5 USD

Basso 2.5 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Treace Medical Concepts Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

4 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 4 che hanno fornito valutazioni azionarie a Treace Medical Concepts Inc - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

7.16 / 7.65Supporto e resistenza

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

There is one bullish event.

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.